Killing Bill C-393 equals killing period. A visual aid for Canadian politicians.

By David Ng at 11:52 am Monday, Mar 21

For the interest of discussion, I've made the above visual aid for members of Canada's Senate, since this is the week that they have a chance to pass a Bill that "aims to make it easier for Canada to export affordable, life-saving, generic medicines to developing countries." I wrote about this Bill C-393 earlier, stating how the right choice (passing the bill and not killing the bill) is obvious. But then it occurred to me that if the decision was so obvious, then why is there so much "push back" from the pharmaceutical industry (as well as the Harper government). It turns out the reason appears to be about Bill C-393 representing a trend that "could potentially" lead to a loss of control over the status quo. This being the status quo that provides the pharmaceutical industry with an inordinate amount of lobbying power to set prices; a business model that values huge profits above innovation; and something that they are so focused on protecting that even the smallest of losses must be avoided no matter the consequences. Which is simply reprehensible - because with this Bill, the consequences are not just about patent control: it's about the livelihood of millions of people, where the decision to "kill" or "not kill" the Bill could literally be a matter of life or death. Please send an email to the Harper government by using this Avaaz link.